Collegium Pharmaceutical
COLL
NZ$50.15
Share price
0.69%
Change (1 day)
-4.42%
Change (1 year)
Categories
Collegium Pharmaceutical (COLL) - Total debt
Total debt on the balance sheet as of March 2025 : NZ$1.38 Billion
According to Collegium Pharmaceutical 's latest financial reports the company's total debt is NZ$1.38 Billion. A company’s total debt is the sum of all current and non-current debts.
Collegium Pharmaceutical - Total debt on balance sheet (from 2014 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | NZ$1.52 B | 42.9% |
| 2023-12-31 | NZ$1.06 B | -4.54% |
| 2022-12-31 | NZ$1.11 B | 194.86% |
| 2021-12-31 | NZ$0.37 B | 2.53% |
| 2020-12-31 | NZ$0.36 B | 1052.3% |
| 2019-12-31 | NZ$32.06 M | 87.02% |
| 2018-12-31 | NZ$17.14 M | 723.26% |
| 2017-12-31 | NZ$2.08 M | -65.21% |
| 2016-12-31 | NZ$5.98 M | -39.87% |
| 2015-12-31 | NZ$9.95 M | -40.04% |
| 2014-12-31 | NZ$16.6 M | 1302.05% |
| 2013-12-31 | NZ$1.18 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Agile Therapeutics
AGRX | NZ$0.47 M | -99.97% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | NZ$4.20 B | 202.94% | 🇮🇪 Ireland |
 United Therapeutics UTHR | NZ$0.32 B | -76.31% | 🇺🇸 USA |
 KemPharm KMPH | NZ$37.99 M | -97.26% | 🇺🇸 USA |